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The activated  form of C4  (C4b) 1 is an essential component of two key enzymes of 
the  classical  pathway,  C3  convertase  (C4b2a)  and  C5  convertase  (C4b2a3b).  The 
function of these enzymes is limited by the decay of C2a, which is very labile at 37°C. 
There  is also evidence  that  another serum  enzyme, C3b-inactivator  (C3bINA)  can 
inhibit  the  activity  of  cell-bound  C4b2a,  probably  by  cleaving  C4b  (1).  Some 
uncertainty exists regarding the activity of C3bINA  on C4b.  According to Shiraishi 
and Stroud (2) the activity of C3bINA on fluid phase C4b required a high molecular 
weight cofactor.  Recent studies of Pangburn et  al.  (3)  have shown that cleavage of 
C4b requires a different protein (fllH)  as an essential cofactor. 
Mouse  (4)  and  human  serum  (5)  contain  a  high  molecular  weight  protein  with 
several  combining  sites  for C4b.  This  protein,  named  C4-hinding protein  (C4-bp), 
differs  from all known complement  components and inactivators. Because  in mouse 
and human serum most or all C4b generated by activation of the complement cascade 
is found in combination with C4-bp, we considered the possibility that C4-bp might 
be  the  cofactor  which  modulates  the  function  and/or  assembly  of  C3  and  C5- 
convertase in the fluid phase. 
Materials and Methods 
Materials.  N,N'-methylene-bis-acrylamide,  acrylamide, N,N,N',N',tetramethylene  diamine 
(TEMED), ammonium persulfate, sodium dodecylsulfate (SDS),  Bio-Rad Laboratories, Rich- 
mond, Calif; ovalbumin,  fl-galactosidase (Escherichia  coh), catalase (beef liver), myoglobin (horse 
heart), alcohol dehydrogenase (yeast), phosphorylase A (rabbit muscle), 2-mercaptoethanol (2- 
ME), Sigma Chemical Co.,  St.  Louis, Mo.;  CNBr-activated Sepharose 4B,  Pharmacia Fine 
Chemicals, Division of Pharmacia Inc., Piseataway, N. J.;  X-omat  R  film XR-5,  Eastman 
Kodak,  Rochester,  N.  Y.;  phosphate-buffered saline (PBS)  (Dulbecco's PBS),  Grand Island 
Biological  Co., Grand Island, N. Y. 
Antisera.  Rabbit  antiserum to  C3bINA was  purchased  from  Kent  Laboratories,  North 
Vancouver, British Columbia. This antiserum reacted against a single component from human 
serum  by  crossed  immunoelectrophoresis and  did  not  react  with  the  serum  of a  patient 
genetically deficient in C3bINA. Anti-flirt was a gift from Dr. D. Fearon, Harvard University 
School of Medicine, Boston,  Mass. Anti-C4-bp was prepared as described previously (5). 
Preparation of Immune  Adsorbents.  The IgG  fractions of anti-fllH and C4-bp, purified by 
* Supporled by grants AI 08499, AI 13809, AI 13224, and CA  16247 from the Natinnal Institutes of 
tleahh. 
i Abbreviations used in this paper: BSA, bovine serum albumin; C4b, aclivated form of C4; C4-bp, C4- 
binding protein; C3bINA, C3b inactivator; 2-ME, 2-mercaptoethanol; PBS, phosphate-buffered saline: 
SDS-PAGE, sodium dodeeylsulfate  polyacrylamide  slab gel electrophoresis. 
1044  J. Exp. MED. © The Rockefeller University Press • 0022-1007/78/1001-104451.00 
Volume 148  October 1978  1044-1051 TEIZO FUJITA,  IRMA GIGLI, AND VICTOR NUSSENZWEIG  1045 
DEAE-cellulose chromatography, were coupled to CNBr-activated Sepharose 4B according to 
the method described in (6). 
Purified Complement Components and Reagents.  C~ and C4 were purified as described (7, 8). C4 
was radiolabeled with 125I by the method describ....ed in (4). Specific activity was 2107 cpm/pg 
protein': C4b was prepared by adding 30 p.g of Cts to 400 #g of C4, and incubating the mixture 
for 48 h at 0°C. Cleavage of the a-chain of C4 was ascertained by SDS-polyacrylamide slab gel 
electrophoresis  (PAGE)  under  reducing  conditions,  fllH  and  C3bINA  were  purifed  from 
human serum according to the method of Weiler et al.  (9) and Fearon and Austen  (I0). To 
remove trace amounts of C4-binding protein, the preparation of fllH was passed through an 
anti-C4-bp Sepharose column. The activity of fltH was measured,  as described in  (9), by its 
inhibitory activity on the EAC4,3B intermediate.  C4-bp was isolated as described previously 
(5). To remove trace contamination of flirt, C4-bp was passed through an anti-fllH Sepharose 
column. 
The protein concentration of C4 was estimated by the method of Hartree (11), using bovine 
serum  albumin  (BSA)  as  standard.  In  the  case of C3bINA, C4-bp,  and  fllH,  the  protein 
concentration was calculated from their optical densities  at  980 nm, assuming an absorption 
coefficient value of E tcm =  l. 
Serum from patients with C4-deficiency and C3b-inactivator deficiency were gifts from Dr. 
H.  Ochs,  University of Washington  School of Medicine,  Seattle,  Wash.;  and  Dr. C.  Alper, 
Harvard University School of Medicine, Boston, Mass.,  respectively. 
Analytical Procedures.  SDS-PAGE was performed as described by Laemmli (12). The stacking 
and separating get combinations used were either 3 and 7.5% or 3 and 10%. Gradient gels, from 
5 to 18% acrylamide, were used in some experiments. After electrophoresis, the gels were stained 
with 0.04% Coomassie blue in  10% methanol and  7% acetic acid. Destaining was carried out 
with a 30% methanol, 7% acetic acid solution. Photographs of the stained gel were taken at this 
stage. Radioautography was carried out by exposing the dried gel to an X-omat R film X  R-5 
at -70°C, for 12-72 h. 
To calibrate  the acrylamide gels  for molecular weight estimations,  the following protein 
markers were used and included in every gel: 94,000 phosphorylase A; 130,000 fl-galactosidase; 
67,000 BSA; 60,000 catalase; 41,000 alcohol dehydrogenase. 
Results 
Native C4 is composed of three  polypeptide chains, a, 13, and y. Treatment  of C4 
with C~ cleaves a  fragment  (C4a)  from the a-chain. The remaining peptide,  named 
C4b, consists of a  fragment of the a-chain  (a'), as well as the intact fl- and y-chains. 
Treatment  of 6 pg C4b with  buffer, 0.6/tg C3blNA, 4/tg fllH,  4/tg C4-bp,  in a 
total  volume of 40/~i,  or by mixtures  of fllH  and  C4-bp,  or C3bINA and fllH  at 
37°C for  1 h  had no effect on the structure  of the C4b molecule  (Fig.  1).  However, 
incubation of C4b with a mixture of C3bINA and C4-bp resulted in the fragmentation 
of the a' chain of C4b into three peptides, with tool wt of 47,000 daltons (a2), 25,000 
daltons (a3), and 17,000 daltons (a4). The fl- and y-chains remained intact  (Table I). 
This  reaction  was not affected by treatment  of the reagents  with  diisopropylfluoro- 
phosphate  (5  ×  10  -a  M).  Treatment  of native  C4  with  C3bINA  and  C4-bp  was 
without effect. 
In view of the report that fllH may function as a  cofactor in the cleavage of C4b 
at  high fllH/C4b  ratios  (3), an additional  experiment  was performed. 0.05 #g in 20 
pl radiolabeled  C4b was mixed with 0.6/tg in 5/~1 C3bINA and 6 #g in  30 pl fllH. 
The  mixture  was  incubated  at  37°C  for  1  h  and  analyzed  by  SDS-PAGE  under 
reducing  conditions.  We  found  no effect  on  the  structure  of C4b.  However,  fllH, 
which had not been passed through an anti-C4-bp Sepharose column, cleaved C4b in 
the presence of C3bINA, indicating that trace amounts of C4-bp were present. 
When labeled C4b, treated with C3bINA and C4-bp, was subjected to SDS-PAGE 
without the reducing agent 2-ME, two fragments, of mol wt  150,000 and 47,000, were 1046  FUNCTION OF C4-bp 
Fro.  I.  Cleavage of C4b  by C3blNA and C4-binding protein.  ~z'~'l-C4b (20 #l, containing 6 #g 
protein)  were incubated with 5 #I, 0.6 ttg C3bINA,  10 #1, 4 #g C4-bp, and  10 #1, 4 #g/~lt| or with 
mixtures of C4-bp and ~llt, C3bINA and/~lI-I, or C3bINA and C4-bp for 60 rain at 37°C in a 
total volume of 40 #1. Then 40 #1 of a solution  coniaining 2% SDS, 6 M urea,  and  10% 2-ME, was 
added, and the mixture applied to a 10% SDS-PAGE. The slab gel was stained,  dried, and subjected 
to radioautography. The radloautography shown  in the panel on the left demonstrates that the a'- 
chain of C4 was cleaved only in the presence of C3bINA and C4-bp.  The a2 and a3 fragments  of 
the a'-chain  are shown,  but  the smaller a4  fragment  migrates with  the dye.  To determine the 
molecular weight of the 4 fragment, ~2'~I-C4b  was treated with buffer or with C3bINA and C4-bp 
under the same conditions and subjected  to 8DS-PAGE in a 5-20% gradient gel. The radioautogram 
in the pand on the right shows the a2, a3 and a4 fragments. 
TABI.~  I 
Fragments and Chains of C4b after Interaction with C3b Inactivator  and C4- 
Binding  Protein 
Chain and fragment  tool wt (mean  +  1 SD) 
a2  47,000  +  1,400 
a3  25,000 ±  1,000 
a4  17,000 +  1,400 
/~-chain  75,000 +  1,200 
y-chain  31,000 _+  1,300 
detected  (Fig. 2). Therefore, the a2  fragment  (probably  C4d)  is not covalently linked 
to the ,8- or -/-chains of C4. 
In  short,  C3bINA  and  C4-bp  cleave  the  a'-chain  at  two  sites,  producing  three 
fragments,  as shown schematically in Fig. 3. 
In  the experiment  shown  in  Fig. 4,  decreasing amounts  of C4-bp  were added  to a 
constant  amount of C4b and C3bINA. The reaction mixtures were incubated at 37°C 
for  60  min  and  subjected  to  SDS-PAGE.  A  stained  gel  is  shown.  The  extent  of 
cleavage of the  C4b  was  dependent  on  the  concentration  of C4-bp.  When  cleavage 
was  incomplete,  the  reaction  did  not  proceed  further  by  prolonging  the  time  of 
incubation  or increasing the concentration  of C3bINA.  Therefore,  it appears  that  an 
optimal stoichiometric relationship between C4b and C4-bp is required for the activity 
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Fit;. 2.  7.5%  slab SDS-PAGE of unreduced samples of ~Z"l-C4b  after treatment  with buffer or with 
C3blNA and C4-bp. The samples were prepared as described in Fig. I except that 2-ME was not 
used. The mol wt of C4d is 47,000 daltons. 
C4a  C4b  C4d  C4e 
,:  s  C3blNA  •  [  ,B  ]  p,  I 
Ft~. 3.  Schematic representation of the cleavage of C4b by C3blNA and C4-bp. 
We also investigated the specificity of interaction between C4b, C3blNA, and C4- 
bp. Radiolabeled C4b  (containing 0.05/tg protein and 5  ×  105 cpm) was incubated 
with the serum of a  patient with genetic deficiency of C3bINA, or with a  mixture of 
C3bINA-deficient serum and purified C3bINA. Also, radiolabeled C4b and C3bINA 
were incubated with C4-bp which had been passed through an anti-C4-bp Sepharose 
column.  After incubation  at  37°C  for  1 h,  the reaction mixtures were  subjected to 
SDS-PAGE under reducing conditions followed by radioautography. The a'-chain of 
C4b was not cleaved when C4-bp was specifically removed, nor after incubation with 
C3bINA-deficient serum. However, after addition of purified C3bINA to the C3bINA- 
deficient  serum,  the  tx'-chain was  cleaved  and  the  a2,  a3,  and  a4  fragments  were 
generated.  Identical results were obtained when  C4b  was  incubated  in  C4-deficient 
serum (Fig. 5). 
Next, we asked whether C4-bp was affected during the interaction of C4b/C4-bp 
complexes  with  C3bINA.  A  mixture  containing  6  #g  of C4b  in  20  ILl, 0.5  #g  of 1048  FUNCTION  OF  C4-bp 
FIG.  4.  Dose-response relationship between the concentration of C4-bp and the extent of cleavage 
of C4b. 5 p,g of C4b in  10 #1 and 0.9 #g of C3blNA in B p.l were incubated with decreasing amounts 
of C4-bp for 1 h  at 37°C in a total volume of 40/~1. The samples were mixed with equal volumes of 
2% SDS and 6  M  urea, and  the mixtures were subjected to  7.5%  SDS-PAGE  under nonreducing 
conditions. A stained gel is shown. Proteolysis of C4b was directly proportional to the concentration 
of C4-bp in the mixture. When C4-bp was limiting, the extent of cleavage of C4b was not changed 
by increasing the time of incubation or the concentration of C3blNA. Three high molecular weight 
contaminants are seen in the preparation of C4b (C4  +  CIs). One of them is an aggregate of C4b, 
which is also cleaved by C4-bp and C3blNA. C4-bp did not penetrate the gel. 
FtG.  5.  Specificity of C4b,  C4-bp,  and C3bINA  interaction.  IZr'l-C4b  (20 #1, containing 0.05/.tg 
protein) was incubated at 37°C for  1 h  with 20 #1 of 1/50 dilution of C3blNA-deficient serum. No 
cleavage of C4b was observed after SDS-PAGE and radioautography (D). However, when 0.2 #g of 
•  '  "  "  n  1~'iI  purified C3blNA was added, the a  -chain of C4b was cleaved into three fragments (E). Whe 
C4b was incubated with C3blNA and a  preparation  of C4-bp which had been treated  with anti- 
C4-bp Sepharose, no cleavage of C4b was observed (F'). Controls consisted of I~'~l-C4b alone  (A), 
and  a  mixture of 12Sl-C4b,  purified C3blNA  (0.2 ~g)  and  C4-bp  (0.6 ,ag)  (B).  Also shown is  the 
cleavage  of  ~'~l-C4b  after  incubation  in  serum  from  a  patient  with  a  genetically  determined 
deficiency of C4 (C). Note that in all cases the cleavage of the a'-chain resulted in fragments of the 
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C3bINA in 10/~1, and 5/~g of lz~I-C4-bp in 15 #1 was incubated at 37°C for 1 h. After 
denaturation and reduction with SDS, urea, and 2-ME, the mixtures were subjected 
to SDS-PAGE. The slab  gel was stained, dried, and subjected to radioautography. 
The stained gel showed the characteristic pattern of degradation of the a'-chain of 
C4b.  In contrast, the radioautography showed that C4-bp had not been cleaved. A 
single band, of mol wt ~75,000, was detected in the mixture containing lz~I-C4-bp, 
C3bINA and C4b, and in the control containing 125I-C4-bp alone (not shown). 
Discussion 
We show here that C4b is cleaved in the presence of C4-bp and C3bINA. Because 
the activity ofC3-convertase (C4b2a) and C5-eonvertase (C4b2a3b) is C4b-dependent, 
it is probable that C4-bp  and C3bINA inhibit  the function of these enzymes. This 
question is currently under investigation in our laboratory. 
Three fragments of the a'-chain of C4b are generated after interaction with C4-bp 
and C3bINA: one of them, (a2), has a mol wt of 47,000 and is noncovalently bound. 
The other two fragments (a3 and a4)  remain associated through disulfide bonds to 
the  rest  of the  molecule.  It  is  very likely that  the  ~x2  fragment  is  the  previously 
described C4d  fragment, whereas  the  disulfide bonded  y-,/~-, a3,  and  a2  peptides 
corresponded to the C4c fragment of C4. 
The precise role of C4-bp  and C3bINA in the cleavage of the a'-chain of C4b is 
unclear. The previous demonstration  that  C4b  forms stable complexes with C4-bp 
and the results of Fig. 4 suggest a  stoichiometric relationship between C4b and C4- 
bp. It is possible, therefore, that the protease is C3bINA, and that its substrate is the 
a'-chain,  modified allosterically by the formation of C4/C4-bp  complexes. Because 
three peptides  are  generated, C3bINA would  have to act  on two separate peptide 
bonds.  Alternatively, C4-bp  might  act enzymatically after complex formation with 
C4b  and C3bINA.  Similar interaction have been described between other subeom- 
ponents of the enzymes of the complement system. For example, some investigators 
report that Clr is activated rapidly when complexed with AgAbClq and Cls, but not 
in the absence of either protein (13). 
There is a  striking homology between the requirements for cleavage of C3b and 
C4b  in  solution  by C3bINA.  In  both  cases an  additional  protein, with  a  specific 
affinity for the substrate, is necessary; ~81H in the case of C3b (3), and C4-bp in the 
case of C4b.  Furthermore, ~81H and C4-bp share some physico-chemical properties, 
and  purified preparations of either protein are frequently cross-contaminated. This 
may explain the results of Pangburn et al. (3) who showed that ~81H can function as 
a cofactor in the cleavage of both C3b and C4b. Although we confirmed that mixtures 
of ~81H (free of C4-bp) and C3bINA cleave C3b, the same preparations of ~81H were 
inactive in relation to C4b. 
Our  findings  support  the  observations of Shiraishi  and  Stroud  (2), who showed 
that a  high molecular weight cofactor and C3bINA were necessary for the cleavage 
of fluid phase C4b  into C4c and C4d.  On  the basis of its activity and some of its 
physico-chemical properties, the high molecular weight cofactor resembles C4-bp. In 
a subsequent publication, Nagasawa and Stroud (14) reported that their preparation 
of cofactor could also function, in conjunction with C3bINA, in the cleavage of the 
a'-chain  of C3b.  This  cleavage  resulted  in  the  complete  abrogation  of the  C3b- 
mediated activation of factor B of the alternative pathway. Their results suggest that 1050  FUNCTION  OF  C4-bp 
similarly to flirt, the high molecular weight cofactor modulates the formation in the 
fluid  phase  of the  alternative  pathway  C3-convertase  (C3bB).  Because  the  high 
molecular weight cofactor and C4-bp may be the same protein, we repeated Nagasawa 
and  Stroud's  experiments and  found  that  our preparations of C4-bp could  indeed 
serve as a  cofactor for cleavage of C3b. 2 However, the interpretation of our findings 
is  complicated  by the  presence  in  the  preparations  of C4-bp of two proteins  with 
slight differences in molecular weights and net charges. As discussed elsewhere, both 
proteins react with the monospecific antiserum to C4-bp and bind to C4b. Whether 
they have similar or different functions in cleavage of C4b and C3b is currently under 
investigation. 
Summary 
We recently described the isolation from human serum of a high molecular weight 
protein with specific binding affinity for fluid-phase activated C4. We show here that 
the C4-binding protein (C4-Bp) functions as an essential cofactor in the proteolysis of 
C4b  in  the  presence of C3b-inactivator  (C3bINA).  C4-bp,  together with  C3bINA, 
cleave the a'-chain of C4b into three fragments called a2, a3, and a4, with mol wt of 
47,000,  25,000,  and  17,000  daltons,  respectively. The  a2  fragment  was  dissociated 
from C4b without reduction, whereas the a3 and a4 fragments were disulfide bonded 
the other chains of C4b. 
The reaction did not occur when either C4-bp or C3bINA were omitted, nor in the 
presence of either protein in combination with filH. Native C4 was not affected by 
C3bINA and C4-bp. 
C4b was not cleaved when incubated in serum of a patient with genetic deficiency 
of C3bINA.  However, when purified C3bINA was added,  the a'-chain of C4b was 
cleaved  and  fragments  with  the  same  molecular  weight  as  a2,  a3,  and  a4  were 
generated. 
We thank Ms. Joanne Joseph for manuscript preparation and John Sorvillo for his technical 
assistance. 
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